True, it's hard to know if one has failed or succeeded if NWBO is still blinded to PFS and OS results. His tone, as always, was very positive about survival. It was undetectable regarding PFS. He is not happy with certain recent inaccurate attacks on the company. I did not receive nor ask for specifics about what was inaccurate.
How dare someone care about the primary endpoint of a clinical trial. An endpoint to which the company has released numerous misleading PRs and tried to steer retail longs from caring about. Remember the 75% of events that flipper claimed was PFS and not yet reached and that turned out to be garbage?
Market Data 
Markets 
AI
